Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists.

Publication

Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists.

Journal Paper/Review - Feb 11, 2022

Glatzer Markus, Petric Primoz, van der Steen-Banasik Elzbieta, Lössl Kristina, Jürgenliemk-Schulz Ina M, Niehoff Peter, Hermansson Ruth S, Nout Remi A, Putora Paul Martin, Plasswilm Ludwig, Nakken Esten Søndrol, Cooper Rachel, Tanderup Kari, Rovirosa Angeles, Fokdal Lars, Ordeanu Claudia, Tagliaferri Luca, Chargari Cyrus, Strnad Vratislav, Dimopoulos Johannes Athanasios, Šegedin Barbara, Tselis Nikolaos

Citation

Glatzer M, Petric P, van der Steen-Banasik E, Lössl K, Jürgenliemk-Schulz I, Niehoff P, Hermansson R, Nout R, Putora P, Plasswilm L, Nakken E, Cooper R, Tanderup K, Rovirosa A, Fokdal L, Ordeanu C, Tagliaferri L, Chargari C, Strnad V, Dimopoulos J, Šegedin B, Tselis N. Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists. Cancers (Basel) 2022; 14

Type

Journal Paper/Review (English)

Journal

Cancers (Basel) 2022; 14

Publication Date

Feb 11, 2022

Issn Print

2072-6694

Brief description/objective

There are various society-specific guidelines addressing adjuvant brachytherapy (BT) after surgery for endometrial cancer (EC). However, these recommendations are not uniform. Against this background, clinicians need to make decisions despite gaps between best scientific evidence and clinical practice. We explored factors influencing decision-making for adjuvant BT in clinical routine among experienced European radiation oncologists in the field of gynaecological radiotherapy (RT). We also investigated the dose and technique of BT.